NICE said there isn't enough evidence Epidiolex is cost-effective for the treatment of Dravet and Lennox-Gastaut syndromes - affecting around 4,600 in the UK.
from News | Mail Online https://ift.tt/30D6hWk
Subscribe to:
Post Comments (Atom)
-
from Pakistani Talk Shows, Latest Pakistan News, Urdu News, Breaking News Pakistan http://bit.ly/2SE0NXv
-
Dailymotion from Pakistani Talk Shows, Latest Pakistan News, Urdu News, Breaking News Pakistan https://ift.tt/2SsPZe5
-
In Haiti, virus crisis leaves cancer patients in limbo In early March, 31-year-old Melchior visited a doctor in his home country of Haiti, ...
No comments:
Post a Comment